Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

THRX 22.13 +0.43 (1.98%)
price chart
What Are Theravance's GSK Drugs Really Worth?
Theravance is falling like a rock after GSK made investor doubt about the prospects of its respiratory drugs. Estimating future sales of these drugs is extremely difficult and we will see how analysts have developed their models and some of the points ...
Theravance to Report Second Quarter 2014 Financial Results on August 6, 2014  MarketWatch
Related articles »  
Investors Alert: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Theravance Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 7/28/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Investor's Watch List - Terex Corporation (NYSE:TEX), Theravance Inc(NASDAQ ...
Theravance Inc(NASDAQ:THRX) recently declared the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the 'closed' triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary disease (COPD).
Theravance Lowered to "Neutral" at Bank of America (THRX)  Watch List News (press release)
Theravance Lowered to �Neutral� at Morgan Stanley (THRX)  Ticker Report
Related articles »  
Volume Buzz: Medivation, Inc. (NASDAQ:MDVN), Theravance Inc. (NASDAQ ...
Lakeway, NY - (MARKET NEWS CALL) - 7/07/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
How Bulls Walk in Biotech Industry- Agenus Inc (NASDAQ:AGEN), Arrowhead ...  eMarketsDaily
Related articles »  
Theravance/Glaxo Commence Global Late stage Study on COPD - Analyst Blog
Theravance, Inc. ( THRX ) and partner GlaxoSmithKline ( GSK ) announced the commencement of a phase III study (IMPACT: n=10,000) to evaluate the safety and efficacy of a triple combination treatment in patients suffering from chronic obstructive ...
GSK and Theravance Announce Initiation of Phase III Programme With Fixed ...  Marketwired (press release)
Related articles »  
Morning Alert � Rite Aid Corporation (NYSE:RAD), Visteon Corp (NYSE:VC ...
Theravance Inc (NASDAQ:THRX) and GlaxoSmithKline plc announced the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the 'closed' triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary ...
Zacks Reiterates �Neutral� Rating for Theravance (THRX)
Theravance Inc logo Theravance (NASDAQ:THRX)'s stock had its �neutral� rating restated by Zacks in a research note issued to investors on Friday.
Related articles »  
Why A Short Covering Rally Might Come for Theravance (THRX) Stock
Many investors appear to be quite bearish on Theravance Inc (THRX - Analyst Report), especially if you look at the percentage of the float that is sold short for this stock.
Related articles »  
Theravance Stock Rating Lowered by Stifel Nicolaus (THRX)
Theravance Inc logo Stifel Nicolaus downgraded shares of Theravance (NASDAQ:THRX) to an underweight rating in a report issued on Monday.
Theravance Rating Reiterated by Zacks (THRX)
Theravance Inc logo Zacks restated their neutral rating on shares of Theravance (NASDAQ:THRX) in a report released on Friday.
Stifel Nicolaus Downgrades Theravance to Underweight (THRX)  Ticker Report
Theravance Stock Rating Reaffirmed by Zacks (THRX)  Watch List News (press release)
Related articles »